MeSH D012512 - ewing sarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Etoposide | Etoposide |  | 1994-02-10 |  |  |
| Cyclophosphamide | Neosar |  | 1993-04-29 |  |  | |
| Etoposide | Toposar |  | 1995-02-27 |  |  | |
| Dr Reddys Laboratories | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 |  |  |
| Mylan | Etoposide | Etoposide |  | 2001-09-19 |  |  |
| Cipla | Cyclophosphamide | Cyclophosphamide |  | 2019-01-18 |  |  |
| Alembic Pharmaceuticals | Cyclophosphamide | Cyclophosphamide |  | 2022-11-10 |  |  |
| Hospira | Etoposide | Etoposide |  | 1995-08-30 |  |  |
| Amneal Pharmaceuticals | Cyclophosphamide | Cyclophosphamide |  | 2018-05-25 |  |  |
| Strides Pharma Global | Etoposide | Vepesid |  | 1986-12-30 |  |  |
| Bristol Myers Squibb | Etoposide | Etopophos |  | 1998-02-27 |  |  |
| Accord Healthcare | Etoposide | Etoposide |  | 1996-03-14 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
73%40/55
Phase 2
13%9/72
Phase 3
24%5/21
Approved: 3Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use